Study of Bemcentinib Plus Pacritinib In Patients With Advanced Lung Adenocarcinoma
Abroad (travel likely)TerminatedPHASE1, PHASE2
Conditions
Advanced Lung Adenocarcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States